The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
now as you say in the Whi even in the overall cohort with an average age of 63 most of the Adverse Events events were relatively rare such as one extra case of breast cancer or heart attack or blood cloth per 1000 women per year I mean it's still important and it can add up with longer term use however it's a low absolute risk
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.